NCT06196294View on ClinicalTrials.gov

GPC3/Mesothelin-CAR-γδT Cells Against Cancers

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

November 30, 2030

Study Completion Date

December 30, 2036

Conditions
Pancreas CancerLung CancerLiver CancerMesotheliomaCAR-T Cell TherapySolid Tumor, Adult
Interventions
BIOLOGICAL

Cell therapy for solid tumors

Transfer γδT cells into patients for anti-ancer therapy.

Trial Locations (1)

510260

RECRUITING

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Second Affiliated Hospital of Guangzhou Medical University

OTHER